Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasms

• Váldodahkkit: Meike Kaehler (Dahkki), Nikolas von Bubnoff (Dahkki), Ingolf Cascorbi (Dahkki), Sivahari Prasad Gorantla (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Leukemia represents a diverse group of hematopoietic neoplasms that can be classified into different subtypes based on the molecular aberration in the affected cell population. Identification of these molecular classification is required to identify specific targeted therapeutic approaches for each...